Manufacturing and Production

Showing 15 posts of 5867 posts found.

shutterstock_2

Gilead to meet rising remdesivir demand in Europe with new supply deal

October 8, 2020 Manufacturing and Production COVID-19, Europe, Gilead

The European Commission (EC) has signed a new joint procurement agreement (JPA) with pharma firm Gilead to improve access to …
bel-n-garijo-large

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO

October 6, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …
headache

Aimovig reduces frequency of episodic migraines, five-year data reveals

October 6, 2020 Manufacturing and Production, Research and Development Aimovig

Amgen and Novartis have revealed new five-year Phase 2 data during the Migraine Trust Virtual Symposium for their calcitonin gene-related …
800px-nhs_nnuh_entrance

NHS warns that UK could face drugs shortages after Brexit stockpile has been used to fight COVID-19

October 6, 2020 Manufacturing and Production

The NHS has warned that hospitals could face shortages of drugs during the second wave of coronavirus due to the …
fda2outsideweb

Opdivo/Yervoy combo secures FDA approval for malignant pleural mesothelioma

October 6, 2020 Manufacturing and Production, Research and Development Bristol-Myers Squibb, Yervoy, bristol myers squibb, opdivo

Bristol Myers Squibb’s therapy regimen of Opdivo (nivolumab) in combination with Yervoy (ipilimumab) has secured FDA approval for the first-line …
fda_21_4_1

White House halts release of new FDA standards for the Emergency Use Authorization of COVID-19 vaccine

October 6, 2020 Manufacturing and Production FDA, Trump, Vaccine, coronavirus vaccines

The Trump White House is blocking new federal guidance for the emergency release of coronavirus vaccines that would essentially ensure …
4353113087_4d19c3a402_b_1

Bristol Myers Squibb agrees $13 billion deal to acquire MyoKardia

October 6, 2020 Manufacturing and Production BSM, FDA, MyoKardia

Bristol Myers Squibb (BMS) is to purchase MyoKardia for $13 billion to boost its heart disease treatments portfolio. The deal …
banner

Across Health to hold first iD.cast webcast ‘Digital Acceleration in Biopharma’ on 15 October

October 2, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, event

Across Health is hosting its first iD.cast webcast, titled Digital Acceleration in Biopharma on 15 October. This ninety-minute webinar online …
bel-n-garijo-large

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO

September 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA

German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The coronavirus news this week focuses on the development of treatments to alleviate symptoms of the virus, as Australian biotech …
reblozyl

Canadian approval for Reblozyl for transfusion-dependent anaemia in beta-thalassemia patients

September 29, 2020 Manufacturing and Production, Sales and Marketing BMS, Canada, Reblozyl

Bristol Myers Squibb and Acceleron have managed to secure regulatory approval in Canada for Reblozyl (luspatercept) for the treatment of …
800px-pfizer_finland_hq_february_13_2009_1

Pfizer’s Xeljanz approved by the FDA for the treatment of children with arthritis

September 29, 2020 Manufacturing and Production

The FDA has approved Pfizer’s Xeljanz (tofacitinib) for the treatment of children and adolescents with active polyarticular course juvenile idiopathic …
president_of_the_united_states_donald_j

Trump announces 150 million Abbott COVID-19 tests will be deployed across the US

September 29, 2020 Manufacturing and Production

President Donald Trump announced on Monday that the government will distribute 150 million coronavirus tests from Abbott Laboratories across the …
fda_21_4

FDA pauses the planning stages of Inovio’s late-stage COVID-19 vaccine trials

September 29, 2020 Manufacturing and Production COVID-19 vaccine, FDA, coronavirus vaccines

The FDA has put Inovio’s planning stages for the final trials of its coronavirus vaccine on hold as the regulator …
The Gateway to Local Adoption Series

Latest content